These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 18857608)
1. [Therapeutic movement; principles and first results of the treatment of so-called essential (ill comitial) epilepsy by the barbiturate-diphenylhydantoin-magnesium sulfate association]. MAHOUDEAU D Sem Hop; 1948 Mar; 24(21):711-3. PubMed ID: 18857608 [No Abstract] [Full Text] [Related]
2. Treatment of epilepsy with diphenylhydantoin sodium (dilantin sodium). LIVINGSTON S Postgrad Med; 1956 Dec; 20(6):584-90. PubMed ID: 13379111 [No Abstract] [Full Text] [Related]
3. [Treatment of epilepsy by barbiturate infiltration of the brain]. JELASIC F Presse Med (1893); 1956 Feb; 64(17):375-6. PubMed ID: 13310542 [No Abstract] [Full Text] [Related]
5. Tridione-diphenylhydantoin combination therapy in grand mal with slow-wave EEG dysrhythmia. BELNAP WD; TOMAN JE; GOODMAN LS Fed Proc; 1947; 6(1):308. PubMed ID: 20343641 [No Abstract] [Full Text] [Related]
6. Objective comparison of phenobarbital and diphenylhydantoin in epileptic patients. GLEN R; GRANT P; GRUBER CM; MOSIER JM Neurology; 1956 Sep; 6(9):640-5. PubMed ID: 13358848 [No Abstract] [Full Text] [Related]
7. [Action of 5,5-diphenylhydantoin on the transmission of epileptic activity, with particular regard to sensory epilepsy according to Clementi]. GIACHETTI A Arch Sci Biol (Bologna); 1949; 33(4):390-8. PubMed ID: 18140328 [No Abstract] [Full Text] [Related]
8. [Action of 5,5-diphenylhydantoin and of dialylbarbituric acid on faradic epilepsy and on reflex epilepsy according to Amantea]. GIACHETTI A Arch Sci Biol (Bologna); 1949; 33(4):375-89. PubMed ID: 18140327 [No Abstract] [Full Text] [Related]
9. [Significance of the attack point of diphenylhydantoin, phenobarbital and the acylureas for our comprehension of the physiopathological mechanism of epilepsy]. FROMMEL E; RADOUCO-THOMAS C Helv Physiol Pharmacol Acta; 1953; 11(2):231-8. PubMed ID: 13095893 [No Abstract] [Full Text] [Related]
10. [Therapeutic use of magnesium glutamate in epilepsy and mental deficiency]. PUECH J; CONSTANS JP Sem Hop; 1954 Nov; 30(75):4170-8. PubMed ID: 13225817 [No Abstract] [Full Text] [Related]
11. [Action of diphenylhydantoin and ethylphenylmalonyluree on subcortical epilepsy]. GLEY P; FOURNIER P; TOUCHARD T C R Seances Soc Biol Fil; 1945 Mar; 139():298. PubMed ID: 21006895 [No Abstract] [Full Text] [Related]
12. Use of parenteral diphenylhydantoin (dilantin) sodium in control of status epilepticus. CARTER CH AMA Arch Neurol Psychiatry; 1958 Feb; 79(2):136-7. PubMed ID: 13497354 [No Abstract] [Full Text] [Related]
13. [Trials with a new barbiturate in the control of epilepsy]. MELIN KA Sven Lakartidn; 1959 Jun; 56(26):1851-7. PubMed ID: 13676047 [No Abstract] [Full Text] [Related]
14. [Further study on paradental changes caused by diphenylhydantoin sodium]. MASI P Riv Ital Stomatol; 1953 Nov; 8(11):1409-26. PubMed ID: 13156396 [No Abstract] [Full Text] [Related]
15. Efficacy of five days' barbiturate anesthesia in the treatment of intractable epilepsies in children. Rantala H; Saukkonen AL; Remes M; Uhari M Epilepsia; 1999 Dec; 40(12):1775-9. PubMed ID: 10612343 [TBL] [Abstract][Full Text] [Related]
19. [Data on cases of "discordance", between the clinical course and electroencephalographic course in a group of 75 epileptics treated with prominal and diphenylhydantoin]. MARCHINI E; MARIANI E Riv Neurol; 1960; 30():287-92. PubMed ID: 13766512 [No Abstract] [Full Text] [Related]
20. Speculations regarding the nature of gingival hyperplasia due to diphenylhydantoin-sodium. VAN DER KWAST WA Acta Med Scand; 1956 Jan; 153(5):399-405. PubMed ID: 13301474 [No Abstract] [Full Text] [Related] [Next] [New Search]